Moneycontrol PRO
Upcoming Event:Join us for the exciting discussion with Danone on role of nutrition, protein in working professionals’ quality of life on July 31, 3pm.
you are here: HomeNewsIndia

For 7th day, Nagaland reports more COVID-19 recoveries than fresh cases

The recovery rate among the COVID-19 patients in the state has gone up to 79.88 per cent from 79.20 per cent on Friday.

June 13, 2021 / 07:57 AM IST
A patient suffering from the coronavirus disease (COVID-19) is wheeled from the casualty ward in Lok Nayak Jai Prakash (LNJP) hospital, amidst the spread of the disease in New Delhi, India April 15, 2021. REUTERS/Danish Siddiqui - RC2AWM9NQQUJ

A patient suffering from the coronavirus disease (COVID-19) is wheeled from the casualty ward in Lok Nayak Jai Prakash (LNJP) hospital, amidst the spread of the disease in New Delhi, India April 15, 2021. REUTERS/Danish Siddiqui - RC2AWM9NQQUJ

Nagaland for the seventh consecutive day reported more COVID-19 recoveries than fresh cases as 235 patients recuperated from the disease and 96 new infections pushed the tally to 23,562, a health department official said.

The recovery rate among the COVID-19 patients in the state has gone up to 79.88 per cent from 79.20 per cent on Friday.

As many as 18,822 people have recovered from the infection in the northeastern state.

'At least 96 positive cases detected today - 38 Kohima, 26 Dimapur, 20 Mokokchung, 4 each in Tuensang and Zunheboto, 2 each in Mon and Phek districts,' State Nodal Officer for Integrated Disease Surveillance Project Dr Nyanthung Kikon said in the daily COVID-19 bulletin.

Nagaland now has 3,633 active COVID-19 cases, he said.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Demise of three COVID-19 patients in Dimapur district increased the death toll in the state to 448, of which 14 are related to other diseases, he said.

Altogether, 659 COVID-19 patients have migrated to other states, he said.

So far, 2,06,708 samples have been tested for COVID- 19 in Nagaland, Dr Kikon said.

As of Friday, 2,80,865 people have been inoculated in the state, including 54,690 who have received the second dose, State Immunisation Officer Dr Ritu Thurr said.
PTI
first published: Jun 13, 2021 07:57 am

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark